KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Return on Assets (2016 - 2025)

Historic Return on Assets for Ionis Pharmaceuticals (IONS) over the last 16 years, with Q3 2025 value amounting to 0.09%.

  • Ionis Pharmaceuticals' Return on Assets rose 400.0% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.15% for FY2024, which is 200.0% down from last year.
  • Per Ionis Pharmaceuticals' latest filing, its Return on Assets stood at 0.09% for Q3 2025, which was up 400.0% from 0.09% recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Return on Assets registered a high of 0.0% during Q3 2022, and its lowest value of 0.25% during Q3 2021.
  • In the last 5 years, Ionis Pharmaceuticals' Return on Assets had a median value of 0.12% in 2023 and averaged 0.12%.
  • As far as peak fluctuations go, Ionis Pharmaceuticals' Return on Assets crashed by -2800bps in 2021, and later skyrocketed by 2500bps in 2022.
  • Quarter analysis of 5 years shows Ionis Pharmaceuticals' Return on Assets stood at 0.01% in 2021, then crashed by -831bps to 0.11% in 2022, then decreased by -14bps to 0.12% in 2023, then decreased by -21bps to 0.15% in 2024, then surged by 43bps to 0.09% in 2025.
  • Its Return on Assets was 0.09% in Q3 2025, compared to 0.09% in Q2 2025 and 0.16% in Q1 2025.